Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0093 | 0.4014 |
Mycobacterium tuberculosis | Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) | 0.2532 | 1 | 0.5 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0026 | 0.0009 | 0.0029 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.0691 | 0.2223 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0804 | 0.311 | 1 |
Mycobacterium ulcerans | pantoate--beta-alanine ligase | 0.2532 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0197 | 0.0691 | 0.2223 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.007 | 0.0182 | 0.0557 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0102 | 0.4395 |
Schistosoma mansoni | bromodomain containing protein | 0.0074 | 0.0198 | 0.0637 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.007 | 0.0182 | 0.0557 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0233 | 1 |
Echinococcus multilocularis | geminin | 0.0197 | 0.0691 | 0.2201 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0804 | 0.311 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0804 | 0.311 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0045 | 0.0082 | 0.2673 |
Brugia malayi | Bromodomain containing protein | 0.0087 | 0.0253 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0071 | 0.0201 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0071 | 0.0201 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0082 | 0.3541 |
Echinococcus granulosus | geminin | 0.0197 | 0.0691 | 0.2201 |
Toxoplasma gondii | pantoate-beta-alanine ligase | 0.2532 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.